TY - JOUR
T1 - Oral complications of radiotherapy
AU - Sciubba, James J.
AU - Goldenberg, David
PY - 2006/2
Y1 - 2006/2
N2 - Radiotherapy-induced damage in the oral mucosa is the result of the deleterious effects of radiation, not only on the oral mucosa itself but also on the adjacent salivary glands, bone, dentition, and masticatory musculature and apparatus. Biological response modifiers, cytoprotective drugs, salivary-sparing radiation techniques, and surgery have been introduced to combat and, more importantly, to prevent, the development of these complications. Radiotherapy-induced oral complications are complex, dynamic pathobiological processes that lower the quality of life and predispose patients to serious clinical disorders. Here, we focus on these oral complications of radiotherapy, highlight preventive and therapeutic developments, and review the current treatment options available for these disorders.
AB - Radiotherapy-induced damage in the oral mucosa is the result of the deleterious effects of radiation, not only on the oral mucosa itself but also on the adjacent salivary glands, bone, dentition, and masticatory musculature and apparatus. Biological response modifiers, cytoprotective drugs, salivary-sparing radiation techniques, and surgery have been introduced to combat and, more importantly, to prevent, the development of these complications. Radiotherapy-induced oral complications are complex, dynamic pathobiological processes that lower the quality of life and predispose patients to serious clinical disorders. Here, we focus on these oral complications of radiotherapy, highlight preventive and therapeutic developments, and review the current treatment options available for these disorders.
UR - http://www.scopus.com/inward/record.url?scp=31544436908&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=31544436908&partnerID=8YFLogxK
U2 - 10.1016/S1470-2045(06)70580-0
DO - 10.1016/S1470-2045(06)70580-0
M3 - Review article
C2 - 16455482
AN - SCOPUS:31544436908
SN - 1470-2045
VL - 7
SP - 175
EP - 183
JO - Lancet Oncology
JF - Lancet Oncology
IS - 2
ER -